Department of Clinical Sciences

photo of cat  

Advancing the health
and well- being
of animals
and people


Kelly Hume

Kelly R. Hume
Cornell University
College of Veterinary Medicine
C3501C CPC, Box 31
Ithaca, NY 14853
P (607) 253-3516
F (607) 253-3055
krh73@cornell.edu

Clinical Trials for Dr. Kelly Hume


TRIALS FOR CATS

Study title: Individualized dosing of carboplatin in cats with injection site sarcomas

  • Inclusion criteria: Cats with histological confirmation of tumor type and a measurable primary tumor or metastatic lesion.

  • Purpose: Determine the response rate and toxicity of carboplatin treatment (dosage based on GFR) in cats with injection site sarcomas. It is hypothesized that individualized dosing of carboplatin based on kidney function will be effective and well tolerated.

  • Benefit: Study pays for cost of GFR, two carboplatin treatments, and CBC monitoring after treatment.